How a Veterans Affairs study can help guide prostate cancer treatment
A nationwide Veterans Affairs (VA) study comparing two leading treatments for metastatic prostate cancer may help doctors choose the right drug for each patient, said a Rutgers Cancer Institute physician-scientist whose invited editorial accompanies the research.
